Jianming Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jianming Peng has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Chenxia Xu
Prenatal Diagnosis Center, Boai Hospital of Zhongshan, Zhongshan, China
2 shared publicationsDegang Wang
Prenatal Diagnosis Center, Boai Hospital of Zhongshan, Zhongshan, China
2 shared publicationsFenghua Xie
Prenatal Diagnosis Center, Boai Hospital of Zhongshan, Zhongshan, China
2 shared publicationsMiaoyuan Li
Department of Urology, The People’s Hospital of Zhongshan, Zhongshan, China
2 shared publicationsTiancai Gu
Prenatal Diagnosis Center, Boai Hospital of Zhongshan, Zhongshan, China
2 shared publicationsYanfang Zhang
Prenatal Diagnosis Center, Boai Hospital of Zhongshan, Zhongshan, China
2 shared publications
Latest Publications
- Open Access
- 30 January 2024
- Published by Springer Nature in Molecular Cytogenetics
- Vol. 17 (1) , 1-7
Chromosomal microarray analysis for prenatal diagnosis of uniparental disomy: a retrospective study
Background: Chromosomal microarray analysis (CMA) is a valuable tool in prenatal diagnosis for the detection of chromosome uniparental disomy (UPD). This retrospective study examines fetuses undergoing invasive prenatal diagnosis through Affymetrix CytoScan 750 K array analysis. We evaluated both chromosome G-banding karyotyping data and CMA results from 2007 cases subjected to amniocentesis. Results: The detection rate of regions of homozygosity (ROH) ≥ 10 Mb was 1.8% (33/2007), with chromosome 11 being the most frequently implicated (17.1%, 6/33). There were three cases where UPD predicted an abnormal phenotype based on imprinted gene expression. Conclusion: The integration of UPD detection by CMA offers a more precise approach to prenatal genetic diagnosis. CMA proves effective in identifying ROH and preventing the birth of children affected by imprinting diseases.
- 30 January 2024
- Published by Springer Nature in Molecular Cytogenetics
- Vol. 17 (1) , 1-7
Open AccessChromosomal microarray analysis for prenatal diagnosis of uniparental disomy: a retrospective study
Background: Chromosomal microarray analysis (CMA) is a valuable tool in prenatal diagnosis for the detection of chromosome uniparental disomy (UPD). This retrospective study examines fetuses undergoing invasive prenatal diagnosis through Affymetrix CytoScan 750 K array analysis. We evaluated both chromosome G-banding karyotyping data and CMA results from 2007 cases subjected to amniocentesis. Results: The detection rate of regions of homozygosity (ROH) ≥ 10 Mb was 1.8% (33/2007), with chromosome 11 being the most frequently implicated (17.1%, 6/33). There were three cases where UPD predicted an abnormal phenotype based on imprinted gene expression. Conclusion: The integration of UPD detection by CMA offers a more precise approach to prenatal genetic diagnosis. CMA proves effective in identifying ROH and preventing the birth of children affected by imprinting diseases.
- Open Access
- 21 August 2023
- Published by Springer Nature in Research Square
Chromosomal Microarray Analysis for Prenatal Diagnosis of Uniparental Disomy: A Retrospective Study
Background: Chromosomal microarray analysis (CMA) is a valuable tool in prenatal diagnosis for detecting chromosome uniparental disomy (UPD). This retrospective study examines fetuses undergoing invasive prenatal diagnosis through Affymetrix CytoScan 750K array analysis. We evaluated both chromosome G-banding karyotyping data and CMA results from 2007 cases subjected to amniocentesis. Results: The detection rate of regions of homozygosity (ROH) ≥10 Mb was 1.8% (33/2007), with chromosome 11 being the most frequently implicated (17.1%, 6/33). CMA successfully identified three cases of UPD stemming from imprinted genes. Conclusion: The combination of karyotyping and CMA can provide a more accurate prenatal genetic diagnosis. CMA proves effective in identifying ROH and in averting the birth of children afflicted with imprinting diseases.
- 21 August 2023
- Published by Springer Nature in Research Square
Open AccessChromosomal Microarray Analysis for Prenatal Diagnosis of Uniparental Disomy: A Retrospective Study
Background: Chromosomal microarray analysis (CMA) is a valuable tool in prenatal diagnosis for detecting chromosome uniparental disomy (UPD). This retrospective study examines fetuses undergoing invasive prenatal diagnosis through Affymetrix CytoScan 750K array analysis. We evaluated both chromosome G-banding karyotyping data and CMA results from 2007 cases subjected to amniocentesis. Results: The detection rate of regions of homozygosity (ROH) ≥10 Mb was 1.8% (33/2007), with chromosome 11 being the most frequently implicated (17.1%, 6/33). CMA successfully identified three cases of UPD stemming from imprinted genes. Conclusion: The combination of karyotyping and CMA can provide a more accurate prenatal genetic diagnosis. CMA proves effective in identifying ROH and in averting the birth of children afflicted with imprinting diseases.